@misc{indiciaeac1112125402,
  title = {Acriflavine, a clinically aproved drug, inhibits SARS-CoV-2 and other betacoronaviruses},
  author = {Napolitano, V. and Dabrowska, A. and Schorpp, K. and Mourao, A. and Barreto-Duran, E. and Benedyk, M. and Botwina, P. and Brandner, S. and Bostock, M. and Chykunova, Y. and Czarna, A. and Dubin, G. and Frohlich, T. and Hoelscher, M. and Jedrysik, M. and Matsuda, A. and Owczarek, K. and Pachota, M. and Plettenburg, O. and Potempa, J. and Rothenaigner, I. and Schlauderer, F. and Szczepanski, A. and Mohn, K. G.-I. and Blomberg, B. and Sattler, M. and Hadian, K. and Popowicz, G. M. and Pyrc, K.},
  year = {2021},
  doi = {10.1101/2021.03.20.436259},
  url = {https://www.biorxiv.org/content/10.1101/2021.03.20.436259v1},
  note = {Source identifier: 10.1101/2021.03.20.436259}
}